相关实验视频
Updated: May 28, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
977
2025年及以后的费德拉提尼布:适应症和未来的应用
Alexander Coltoff1, John Mascarenhas2
1Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
Blood advances
|February 14, 2025
概括
费德拉提尼布是一种JAK抑制剂,通过向JAK2和其他激酶,有效治疗髓纤维化. 早期治疗胃肠道毒性和韦尼克脑病变等副作用对于最佳的患者结果至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓纤维化是一种由失调的JAK/STAT信号驱动的骨髓增殖性瘤.
- 细胞衰竭,壮和宪法症状是骨髓纤维化症的特征.
- 雅克抑制剂是高风险或有症状的骨髓纤维化的主要治疗方法.
研究的目的:
- 审查费德拉提尼布在骨髓纤维化治疗中的作用.
- 为了突出fedratinib独特的激酶抑制特征.
- 讨论其在一线和二线设置中的有效性.
主要方法:
- 临床证据和费德拉提尼布的药理性质的审查.
- 对JAK2和其他激酶 (例如FLT3,BRD4) 的费德拉提尼布选择性的分析.
- 讨论治疗策略,包括毒性管理和潜在的新适应症.
主要成果:
- 费德拉提尼布表现出偏好的JAK2抑制,并影响其他激酶.
- 它既有效作为一线和二线药物治疗骨髓纤维化.
- 管理胃肠道毒性和监测韦尼克脑病变是非常重要的.
结论:
- 费德拉提尼布是一种有价值的治疗选择,用于骨髓纤维化.
- 它的特定基因组形状表明其在其他血液病症中的潜力.
- 目前正在进行的研究正在探索其在骨髓疏松/骨髓扩散性瘤和移植后维护中的应用.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)
